Cote Fund for Orphan Drugs, LP — Form D

Cote Fund for Orphan Drugs, LP of WASHINGTON, DC, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2018-04-13. Industry: Pooled Investment Fund.

Offering

• Filed: 2018-04-13
• Form: D
• Accession: 0001736112-18-000001
• Industry: Pooled Investment Fund
• Exemptions: 06b, 3C, 3C.1
• Minimum investment: $100K
• Security types: equity, fund interests
• SEC file number: 021-310197

Issuer

• Name: Cote Fund for Orphan Drugs, LP
• CIK: 0001736112
• Entity type: Limited Partnership
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 3529 TILDEN STREET NW, WASHINGTON, DC, 20008
• Phone: 202-738-6336

Officers, directors & promoters (1)

More

• CIK 1736112 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search